Provided is an intraesophageal electrostimulator configured so that other medical tools can also be easily inserted into an esophagus and misalignment in the esophagus can be reduced. An intraesophageal electrostimulator 100 includes a stimulator body 101, stimulating electrodes 111, 112, and power feed lines 113, 114. The stimulator body 101 is formed, in order to insert the stimulator body 101 into an esophagus S, in an elongated flat plate shape with flexibility in a longitudinal direction. The stimulator body 101 includes a first flat plate member 102, a second flat plate member 103, and an exterior body 104. On one plate surface of the first flat plate member 102, each of the stimulating electrodes 111, 112 is provided so as to protrude from the plate surface. The second flat plate member 103 overlaps with the other plate surface of the first flat plate member 102 such that the second flat plate member 103 and the first flat plate member 102 sandwich the power feed lines 113, 114. The exterior body 104 covers the first flat plate member 102 and the second flat plate member 103 overlapping with each other.
Compositions and methods related to annexin 1-binding compounds. Also compositions comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Isolated nucleic acids comprising a nucleic acid sequence encoding a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Methods comprising administering to a subject a composition comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Methods of targeting a tumor cell in a subject comprising administering to the subject a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Methods of targeting a tumor cell in a subject comprising administering to the subject a composition comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell.
A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
3.
DEVICE FOR EMITTING LIGHT HAVING LOW ATTRACTION TO INSECTS, DISPLAY DEVICE, METHOD FOR EMITTING LIGHT HAVING LOW ATTRACTION TO INSECTS, AND DISPLAY METHOD
ISHIKAWA PREFECTURAL PUBLIC UNIVERSITY CORPORATION (Japan)
Inventor
Hironaka Mantaro
Abstract
A device (10) for emitting light having a low attraction to insects comprises a light emitting part (11) and a driving part (13). The light emitting part (11) constituting the device (10) for emitting light having a low attraction to insects emits light. The driving part (13) constituting the device (10) for emitting light having a low attraction to insects generates flickering light by controlling the intensity of the light emitted by the light emitting part (11). The waveform of the intensity of the flickering light generated via the control performed by the driving part (13) contains more of a specific frequency component, which corresponds to the type of insect for which the attraction rate is to be lowered compared to when the light emitting part (11) emits continuous light, than other frequency components.
A01M 29/10 - Scaring or repelling devices, e.g. bird-scaring apparatus using visual means, e.g. scarecrows, moving elements, specific shapes, patterns or the like using light sources, e.g. lasers or flashing lights
F21K 9/23 - Retrofit light sources for lighting devices with a single fitting for each light source, e.g. for substitution of incandescent lamps with bayonet or threaded fittings
F21K 9/27 - Retrofit light sources for lighting devices with two fittings for each light source, e.g. for substitution of fluorescent tubes
F21S 2/00 - Systems of lighting devices, not provided for in main groups or , e.g. of modular construction
F21S 8/08 - Lighting devices intended for fixed installation with a standard
G09F 13/02 - Signs, boards, or panels, illuminated by artificial light sources positioned in front of the insignia
H01L 33/00 - SEMICONDUCTOR DEVICES NOT COVERED BY CLASS - Details thereof
F21W 111/02 - Use or application of lighting devices or systems for signalling, marking or indicating, not provided for in groups for roads, paths or the like
F21W 131/103 - Outdoor lighting of streets or roads
F21W 131/405 - Lighting for industrial, commercial, recreational or military use for shop-windows or displays
F21Y 103/10 - Elongate light sources, e.g. fluorescent tubes comprising a linear array of point-like light-generating elements
F21Y 105/10 - Planar light sources comprising a two-dimensional array of point-like light-generating elements
F21Y 107/20 - Light sources with three-dimensionally disposed light-generating elements on convex supports or substrates, e.g. on the outer surface of spheres
F21Y 113/13 - Combination of light sources of different colours comprising an assembly of point-like light sources
The purpose of the present invention is to provide a device for display of medical equipment and supplies which is capable of displaying side by side a plurality of images of medical equipment and supplies. Provided is a device for display of medical equipment and supplies, comprising: an image storage unit which stores a plurality of instances of image data of medical equipment and supplies; a search unit which carries out, with a prescribed condition, a search of the image data which is stored in the image storage unit; and a display control unit which causes a display unit to display side by side a first medical equipment and supplies image and a second medical equipment and supplies image which differs from the first medical equipment and supplies image, said first medical equipment and supplies image being selected from thumbnail images which are based on a plurality of instances of the image data which have been obtained by the search.
G06Q 50/22 - Social work or social welfare, e.g. community support activities or counselling services
A61B 90/00 - Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups , e.g. for luxation treatment or for protecting wound edges
5.
COMPOSITIONS AND METHODS FOR TARGETED ENDOMETRIOSIS TREATMENT
Disclosed are compositions and methods for selectively targeting an endometriosis cell. Also disclosed are compositions and methods for treating endometriosis.
A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
C07K 7/06 - Linear peptides containing only normal peptide links having 5 to 11 amino acids
C07K 7/08 - Linear peptides containing only normal peptide links having 12 to 20 amino acids
C07K 14/00 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
6.
Attraction device, insect-capturing apparatus and insect-capturing method
By plates (31, 32) having different colors, an edge is formed in the vertical direction along the boundary between the plates (31, 32). Further, as materials of the plates (31, 32), a material which primarily transmits ultraviolet light having a wavelength of about 370 nm and a material which primarily transmits green light having a wavelength of about 520 nm are used. This constitution makes an attraction device (10) capable of attracting insect pests more efficiently as compared to a case where a light source such as a mercury lamp which emits a large amount of light having a wavelength of 300 to 600 nm or an LED which emits a large amount of light having a relatively short wavelength is used.
By plates (31, 32) which have different colors, an edge is formed in the plumb direction which follows the interface of the plates (31, 32). As materials of the plates (31, 32), a material which primarily transmits ultraviolet light with a wavelength on the order of 370nm, and a material which primarily transmits green light with a wavelength on the order of 520nm, are employed. It is thus possible for an induction device (10) to induce insects more efficiently than when using a light source such as a mercury lamp which largely emits light with a wavelength of 300-600nm or an LED which largely emits light with a relatively short wavelength.
Disclosed are conjugates comprising the annexin 1-binding peptide IFLLWQR covalently linked to a therapeutic or detectable agent. Also disclosed are compositions comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are isolated nucleic acids comprising a nucleic acid sequence encoding a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods comprising administering to a subject a composition comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods of targeting a tumor cell in a subject comprising administering to the subject a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods of targeting a tumor cell in a subject comprising administering to the subject a composition comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. The disclosed targeting is useful for treatment of, for example, cancer.
A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
9.
METHODS AND COMPOSITIONS RELATED TO ANNEXIN 1-BINDING COMPOUNDS
Disclosed are conjugates comprising the annexin 1 -binding peptide IFLLWQR covalently linked to a therapeutic or detectable agent. Also disclosed are compositions comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are isolated nucleic acids comprising a nucleic acid sequence encoding a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods comprising administering to a subject a composition comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods of targeting a tumor cell in a subject comprising administering to the subject a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. Also disclosed are methods of targeting a tumor cell in a subject comprising administering to the subject a composition comprising a moiety and a peptide comprising an amino acid sequence that can bind to a carbohydrate receptor on a cell. The disclosed targeting is useful for treatment of, for example, cancer.
A61K 47/48 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
Disclosed is an endermic method for performing endermism of drugs and chemicals surely even if a microneedle is short, and a needle organizer for use in the method and an endermic injector device. A needle organizer (1) provided, on the surface thereof, with a portion (3) where a plurality of microneedles (2) are arranged collectively is applied to a part of a skin (18) from which a stratum corneum is stripped, and then drugs and chemicals are injected into the skin from the microneedles (2) in the portion (3) where a plurality of microneedles are arranged collectively. The portion (3) where a plurality of microneedles (2) are arranged collectively and a convex surface is formed on the surface thereof is formed on the top of the surface, and one or more liquid passing holes (4) are formed to penetrate the needle organizer (1) from the back surface to the front surface.
patents
